UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 461

Sortiert nach

Burnout and associated factors among members of the Society of Gynecologic Oncology

American journal of obstetrics and gynecology, 2015-12, Vol.213 (6), p.824.e1-824.e9

2015

Link zum Volltext

Verfügbarkeit prüfen

Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3786-3791

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1419-1425

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3194-3200

2003

Link zum Volltext

Verfügbarkeit prüfen

The role of robotic surgery in endometrial cancer

Journal of surgical oncology, 2015-12, Vol.112 (7), p.761-768

2015

Link zum Volltext

Verfügbarkeit prüfen

A detailed analysis of the learning curve: Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer

Gynecologic oncology, 2009-08, Vol.114 (2), p.162-167

2009

Link zum Volltext

Verfügbarkeit prüfen

HER-2 Is an Independent Prognostic Factor in Endometrial Cancer: Association With Outcome in a Large Cohort of Surgically Staged Patients

Journal of clinical oncology, 2006-05, Vol.24 (15), p.2376-2385

2006

Link zum Volltext

Verfügbarkeit prüfen

Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?

Gynecologic oncology, 2017-02, Vol.144 (2), p.290-293

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1001-1007

2001

Link zum Volltext

Verfügbarkeit prüfen

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173

Gynecologic oncology, 2013-02, Vol.128 (2), p.155-159

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations

Surgical oncology, 2020-09, Vol.34, p.40-45

2020

Link zum Volltext

Verfügbarkeit prüfen

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study

Gynecologic oncology, 2018-01, Vol.148 (1), p.49-55

2018

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort

International journal of gynecological cancer, 2016-11, Vol.26 (9), p.1717-1721

2016

Link zum Volltext

Verfügbarkeit prüfen

Swelling Among Women Who Need Education About Leg Lymphedema: A Descriptive Study of Lymphedema in Women Undergoing Surgery for Endometrial Cancer

International journal of gynecological cancer, 2014-10, Vol.24 (8), p.1507-1512

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5270-5277

2009

Link zum Volltext

Verfügbarkeit prüfen

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Journal of clinical oncology, 2019-09, Vol.37 (26), p.2317-2328

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer

Gynecologic oncology, 2009-09, Vol.114 (3), p.486-490

2009

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine carcinoma of the uterine cervix: The role of multimodality therapy in early-stage disease

Gynecologic oncology, 2013-04, Vol.129 (1), p.135-139

2013

Link zum Volltext

Verfügbarkeit prüfen

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer

Gynecologic oncology, 2011-05, Vol.121 (2), p.269-272

2011

Link zum Volltext

Verfügbarkeit prüfen

A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer

Journal of minimally invasive gynecology, 2016-03, Vol.23 (3), p.429-434

2016

Link zum Volltext

Verfügbarkeit prüfen

Translating Response During Therapy into Ultimate Treatment Outcome: A Personalized 4-Dimensional MRI Tumor Volumetric Regression Approach in Cervical Cancer

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.719-727

2010

Link zum Volltext

Verfügbarkeit prüfen

Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)

Gynecologic oncology, 2019-06, Vol.153 (3), p.496-499

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy

International journal of gynecological cancer, 2015-09, Vol.25 (7), p.1331-1336

2015

Link zum Volltext

Verfügbarkeit prüfen

Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer

Gynecologic oncology, 2008-12, Vol.111 (3), p.461-466

2008

Link zum Volltext

Verfügbarkeit prüfen

Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia

American journal of obstetrics and gynecology, 2020-01, Vol.222 (1), p.60.e1-60.e7

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 461

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(413)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(460)
Japanisch
(66)

Erscheinungsjahr

n.n

Thema

Science & Technology
(343)
Life Sciences & Biomedicine
(279)
Humans
(256)
Female
(201)
Middle Aged
(140)
Aged
(114)
Adult
(111)
Oncology
(105)
Obstetrics & Gynecology
(99)
Male
(89)
Biological And Medical Sciences
(88)
Medical Sciences
(80)
Neoplasm Staging
(52)
Obstetrics And Gynecology
(50)
Aged, 80 And Over
(49)
Treatment Outcome
(47)
Retrospective Studies
(42)
Hematology, Oncology And Palliative Medicine
(40)
Endometrial Neoplasms - Pathology
(37)
Tumors
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Burnout and associated factors among members of the Society of Gynecologic Oncology

Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A Gynecologic Oncology Group Study

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

The role of robotic surgery in endometrial cancer

A detailed analysis of the learning curve: Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer

HER-2 Is an Independent Prognostic Factor in Endometrial Cancer: Association With Outcome in a Large Cohort of Surgically Staged Patients

Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study

Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort

Swelling Among Women Who Need Education About Leg Lymphedema: A Descriptive Study of Lymphedema in Women Undergoing Surgery for Endometrial Cancer

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer

Neuroendocrine carcinoma of the uterine cervix: The role of multimodality therapy in early-stage disease

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer

A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer

Translating Response During Therapy into Ultimate Treatment Outcome: A Personalized 4-Dimensional MRI Tumor Volumetric Regression Approach in Cervical Cancer

Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)

Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy

Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer

Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia

Suchergebnisse filtern